Skip to main content
. Author manuscript; available in PMC: 2019 Oct 1.
Published in final edited form as: Lancet Oncol. 2018 Sep 17;19(10):1351–1359. doi: 10.1016/S1470-2045(18)30487-X

Table 1:

Patient Demographics

Characteristic N (% unless specified)
Total Patient Number 32
Gender
Female 18 (56)
Male 14 (44)
Median age 38 (IQR 32-42)
VHL Status
Confirmed VHL mutation 24 (75)
Patient not tested but positive family history 4 (13)
Tested negative for VHL mutation but had clinical features of von Hippel-Lindau disease 4 (13)
Lesions (Any Per Patient)
Central nervous system 23 (72)
Kidney 22 (69)
Pancreas 9 (28)
Eye 3 (9)
Adrenal 1 (3)
Number of Organ Sites Involved (Per Patient)
1 11 (34)
2 16 (50)
3 5 (16)